InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
33%
T+90 mean return
-11.0%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by SLONIN JONATHAN, Directeur Clinique. Officer active across 1 company, notably Pacira BioSciences, Inc.. In total, 14 filings have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €240k. Activity tracked since 3 August 2021. The latest transaction was disclosed on 1 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
93,600 shares0Common StockSEC:0001396814-25-000033:0
371 shares@ US$18.331.6% of flowCommon StockSEC:0001396814-25-000007:0
305 shares@ US$20.751.4% of flowCommon StockSEC:0001396814-24-000100:0
437.271 shares@ US$24.3192.4% of flowCommon StockSEC:0001396814-24-000088:0
5,012 shares@ US$28.5732.9% of flowCommon StockSEC:0001396814-24-000084:0
1,615 shares@ US$30.8911.3% of flowCommon StockSEC:0001396814-24-000051:0
5,000 shares0Common StockSEC:0001396814-24-000013:0
471 shares@ US$38.9914.2% of flowCommon StockSEC:0001209191-23-035263:0
308 shares@ US$55.704.2% of flowCommon StockSEC:0001209191-22-044554:0
924 shares@ US$57.18812.7% of flowCommon StockSEC:0001209191-22-041521:0
362 shares@ US$61.3740.0020% mcap17.5% of flowCommon StockSEC:0001209191-22-035232:0
2,000 shares@ US$52.370.0092% mcap82.5% of flowCommon StockSEC:0001209191-22-031854:0
5,000 shares0Common StockSEC:0001209191-21-049940:0
5,000 shares0Common StockSEC:0001209191-21-049940
14 of 14 declarations
About SLONIN JONATHAN
Jonathan Slonin serves as Chief Clinical Officer at Pacira BioSciences, Inc. He is responsible for the company's clinical strategy, overseeing research and development initiatives. His expertise is essential for innovation and regulatory compliance.
